Previous studies have documented that abnormal glycolysis results in excessive expression of EZH2 in CD4+ T cells of SLE patients, which is responsible for the abnormalities of CD4+ T cells (10, 16, 43). This evidence concerns the gene EZH2 and systemic lupus erythematosus.